nodes	percent_of_prediction	percent_of_DWPC	metapath
Delavirdine—CYP2D6—Hydroxyurea—head and neck cancer	0.143	0.2	CbGbCtD
Delavirdine—CYP3A7—Docetaxel—head and neck cancer	0.0908	0.127	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0908	0.127	CbGbCtD
Delavirdine—CYP2C8—Fluorouracil—head and neck cancer	0.0858	0.12	CbGbCtD
Delavirdine—CYP3A5—Docetaxel—head and neck cancer	0.0681	0.0954	CbGbCtD
Delavirdine—CYP1A2—Fluorouracil—head and neck cancer	0.0664	0.0929	CbGbCtD
Delavirdine—CYP2C9—Fluorouracil—head and neck cancer	0.0598	0.0837	CbGbCtD
Delavirdine—CYP2D6—Vinblastine—head and neck cancer	0.0507	0.0709	CbGbCtD
Delavirdine—CYP3A4—Vinblastine—head and neck cancer	0.0322	0.0451	CbGbCtD
Delavirdine—CYP3A4—Docetaxel—head and neck cancer	0.0266	0.0372	CbGbCtD
Delavirdine—Blister—Hydroxyurea—head and neck cancer	0.0028	0.011	CcSEcCtD
Delavirdine—Blepharitis—Fluorouracil—head and neck cancer	0.00236	0.00925	CcSEcCtD
Delavirdine—Bone pain—Vinblastine—head and neck cancer	0.00231	0.00904	CcSEcCtD
Delavirdine—Amenorrhoea—Hydroxyurea—head and neck cancer	0.0023	0.00899	CcSEcCtD
Delavirdine—Nail disorder—Fluorouracil—head and neck cancer	0.00224	0.00877	CcSEcCtD
Delavirdine—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.00218	0.00852	CcSEcCtD
Delavirdine—Ulcer—Hydroxyurea—head and neck cancer	0.00213	0.00835	CcSEcCtD
Delavirdine—Photophobia—Vinblastine—head and neck cancer	0.00208	0.00813	CcSEcCtD
Delavirdine—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.00206	0.00805	CcSEcCtD
Delavirdine—Nystagmus—Fluorouracil—head and neck cancer	0.00203	0.00796	CcSEcCtD
Delavirdine—Blister—Fluorouracil—head and neck cancer	0.00202	0.00789	CcSEcCtD
Delavirdine—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00193	0.00754	CcSEcCtD
Delavirdine—Necrosis—Fluorouracil—head and neck cancer	0.00185	0.00725	CcSEcCtD
Delavirdine—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00183	0.00718	CcSEcCtD
Delavirdine—Tingling sensation—Fluorouracil—head and neck cancer	0.00181	0.00707	CcSEcCtD
Delavirdine—Disorientation—Hydroxyurea—head and neck cancer	0.00164	0.00641	CcSEcCtD
Delavirdine—Hepatic failure—Hydroxyurea—head and neck cancer	0.00163	0.00638	CcSEcCtD
Delavirdine—Parosmia—Docetaxel—head and neck cancer	0.00162	0.00633	CcSEcCtD
Delavirdine—Nail disorder—Docetaxel—head and neck cancer	0.00162	0.00633	CcSEcCtD
Delavirdine—Renal failure acute—Hydroxyurea—head and neck cancer	0.00159	0.00621	CcSEcCtD
Delavirdine—Ulcer—Fluorouracil—head and neck cancer	0.00154	0.00601	CcSEcCtD
Delavirdine—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00153	0.006	CcSEcCtD
Delavirdine—Inflammation—Fluorouracil—head and neck cancer	0.0015	0.00586	CcSEcCtD
Delavirdine—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00137	0.00537	CcSEcCtD
Delavirdine—Photophobia—Fluorouracil—head and neck cancer	0.00136	0.00534	CcSEcCtD
Delavirdine—Otitis media—Docetaxel—head and neck cancer	0.00135	0.00527	CcSEcCtD
Delavirdine—Necrosis—Docetaxel—head and neck cancer	0.00134	0.00523	CcSEcCtD
Delavirdine—Oesophagitis—Fluorouracil—head and neck cancer	0.00133	0.0052	CcSEcCtD
Delavirdine—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00132	0.00517	CcSEcCtD
Delavirdine—Pancytopenia—Vinblastine—head and neck cancer	0.00132	0.00516	CcSEcCtD
Delavirdine—Euphoric mood—Fluorouracil—head and neck cancer	0.00125	0.00489	CcSEcCtD
Delavirdine—Pancreatitis—Hydroxyurea—head and neck cancer	0.00124	0.00486	CcSEcCtD
Delavirdine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00121	0.00475	CcSEcCtD
Delavirdine—Pancytopenia—Hydroxyurea—head and neck cancer	0.0012	0.00471	CcSEcCtD
Delavirdine—Swelling—Fluorouracil—head and neck cancer	0.0012	0.00468	CcSEcCtD
Delavirdine—Amenorrhoea—Docetaxel—head and neck cancer	0.00119	0.00467	CcSEcCtD
Delavirdine—Neutropenia—Hydroxyurea—head and neck cancer	0.00118	0.00464	CcSEcCtD
Delavirdine—Disorientation—Fluorouracil—head and neck cancer	0.00118	0.00461	CcSEcCtD
Delavirdine—Bone disorder—Docetaxel—head and neck cancer	0.00116	0.00454	CcSEcCtD
Delavirdine—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.00115	0.00451	CcSEcCtD
Delavirdine—Weight increased—Hydroxyurea—head and neck cancer	0.00115	0.00451	CcSEcCtD
Delavirdine—Drug interaction—Docetaxel—head and neck cancer	0.00113	0.00442	CcSEcCtD
Delavirdine—Amnesia—Fluorouracil—head and neck cancer	0.00112	0.00439	CcSEcCtD
Delavirdine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00111	0.00433	CcSEcCtD
Delavirdine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00111	0.00433	CcSEcCtD
Delavirdine—Dermatitis bullous—Fluorouracil—head and neck cancer	0.0011	0.00432	CcSEcCtD
Delavirdine—Pharyngitis—Vinblastine—head and neck cancer	0.0011	0.00432	CcSEcCtD
Delavirdine—Stomatitis—Hydroxyurea—head and neck cancer	0.0011	0.00431	CcSEcCtD
Delavirdine—Bone pain—Docetaxel—head and neck cancer	0.00109	0.00428	CcSEcCtD
Delavirdine—Inflammation—Docetaxel—head and neck cancer	0.00108	0.00423	CcSEcCtD
Delavirdine—Cardiac failure—Fluorouracil—head and neck cancer	0.00108	0.00423	CcSEcCtD
Delavirdine—Lethargy—Fluorouracil—head and neck cancer	0.00108	0.00421	CcSEcCtD
Delavirdine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00105	0.00413	CcSEcCtD
Delavirdine—Hallucination—Hydroxyurea—head and neck cancer	0.00101	0.00395	CcSEcCtD
Delavirdine—Colitis—Docetaxel—head and neck cancer	0.00101	0.00394	CcSEcCtD
Delavirdine—Skin exfoliation—Docetaxel—head and neck cancer	0.001	0.00392	CcSEcCtD
Delavirdine—Candida infection—Docetaxel—head and neck cancer	0.001	0.00392	CcSEcCtD
Delavirdine—Neuropathy—Docetaxel—head and neck cancer	0.000984	0.00385	CcSEcCtD
Delavirdine—Alopecia—Vinblastine—head and neck cancer	0.000982	0.00384	CcSEcCtD
Delavirdine—Dry skin—Fluorouracil—head and neck cancer	0.000967	0.00378	CcSEcCtD
Delavirdine—Oesophagitis—Docetaxel—head and neck cancer	0.000958	0.00375	CcSEcCtD
Delavirdine—Muscular weakness—Fluorouracil—head and neck cancer	0.00093	0.00364	CcSEcCtD
Delavirdine—Dysphagia—Fluorouracil—head and neck cancer	0.000911	0.00357	CcSEcCtD
Delavirdine—Chills—Hydroxyurea—head and neck cancer	0.000909	0.00356	CcSEcCtD
Delavirdine—Eosinophilia—Fluorouracil—head and neck cancer	0.000902	0.00353	CcSEcCtD
Delavirdine—Ill-defined disorder—Vinblastine—head and neck cancer	0.000898	0.00351	CcSEcCtD
Delavirdine—Alopecia—Hydroxyurea—head and neck cancer	0.000896	0.00351	CcSEcCtD
Delavirdine—Anaemia—Vinblastine—head and neck cancer	0.000894	0.0035	CcSEcCtD
Delavirdine—Erythema—Hydroxyurea—head and neck cancer	0.000882	0.00345	CcSEcCtD
Delavirdine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000875	0.00343	CcSEcCtD
Delavirdine—Malaise—Vinblastine—head and neck cancer	0.000872	0.00342	CcSEcCtD
Delavirdine—Vertigo—Vinblastine—head and neck cancer	0.000869	0.0034	CcSEcCtD
Delavirdine—Leukopenia—Vinblastine—head and neck cancer	0.000866	0.00339	CcSEcCtD
Delavirdine—Pancytopenia—Fluorouracil—head and neck cancer	0.000866	0.00339	CcSEcCtD
Delavirdine—Swelling—Docetaxel—head and neck cancer	0.000863	0.00338	CcSEcCtD
Delavirdine—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000847	0.00332	CcSEcCtD
Delavirdine—Hepatic failure—Docetaxel—head and neck cancer	0.000847	0.00332	CcSEcCtD
Delavirdine—Hypertension—Vinblastine—head and neck cancer	0.000835	0.00327	CcSEcCtD
Delavirdine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000819	0.0032	CcSEcCtD
Delavirdine—Pneumonia—Fluorouracil—head and neck cancer	0.000817	0.0032	CcSEcCtD
Delavirdine—Anaemia—Hydroxyurea—head and neck cancer	0.000815	0.00319	CcSEcCtD
Delavirdine—Discomfort—Vinblastine—head and neck cancer	0.000814	0.00319	CcSEcCtD
Delavirdine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000797	0.00312	CcSEcCtD
Delavirdine—Dermatitis bullous—Docetaxel—head and neck cancer	0.000796	0.00312	CcSEcCtD
Delavirdine—Malaise—Hydroxyurea—head and neck cancer	0.000796	0.00311	CcSEcCtD
Delavirdine—Stomatitis—Fluorouracil—head and neck cancer	0.000792	0.0031	CcSEcCtD
Delavirdine—Conjunctivitis—Fluorouracil—head and neck cancer	0.00079	0.00309	CcSEcCtD
Delavirdine—Urinary tract infection—Fluorouracil—head and neck cancer	0.00079	0.00309	CcSEcCtD
Delavirdine—Leukopenia—Hydroxyurea—head and neck cancer	0.00079	0.00309	CcSEcCtD
Delavirdine—Cardiac failure—Docetaxel—head and neck cancer	0.00078	0.00305	CcSEcCtD
Delavirdine—Lethargy—Docetaxel—head and neck cancer	0.000777	0.00304	CcSEcCtD
Delavirdine—Thrombocytopenia—Vinblastine—head and neck cancer	0.000773	0.00303	CcSEcCtD
Delavirdine—Epistaxis—Fluorouracil—head and neck cancer	0.000766	0.003	CcSEcCtD
Delavirdine—Hyponatraemia—Docetaxel—head and neck cancer	0.000764	0.00299	CcSEcCtD
Delavirdine—Sinusitis—Fluorouracil—head and neck cancer	0.000762	0.00298	CcSEcCtD
Delavirdine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000761	0.00298	CcSEcCtD
Delavirdine—Anorexia—Vinblastine—head and neck cancer	0.000753	0.00295	CcSEcCtD
Delavirdine—Migraine—Docetaxel—head and neck cancer	0.000749	0.00293	CcSEcCtD
Delavirdine—Discomfort—Hydroxyurea—head and neck cancer	0.000742	0.00291	CcSEcCtD
Delavirdine—Rhinitis—Fluorouracil—head and neck cancer	0.000731	0.00286	CcSEcCtD
Delavirdine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000726	0.00284	CcSEcCtD
Delavirdine—Pharyngitis—Fluorouracil—head and neck cancer	0.000724	0.00283	CcSEcCtD
Delavirdine—Oedema—Hydroxyurea—head and neck cancer	0.00072	0.00282	CcSEcCtD
Delavirdine—Infection—Hydroxyurea—head and neck cancer	0.000715	0.0028	CcSEcCtD
Delavirdine—Paraesthesia—Vinblastine—head and neck cancer	0.000709	0.00278	CcSEcCtD
Delavirdine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000705	0.00276	CcSEcCtD
Delavirdine—Skin disorder—Hydroxyurea—head and neck cancer	0.000699	0.00274	CcSEcCtD
Delavirdine—Dry skin—Docetaxel—head and neck cancer	0.000698	0.00273	CcSEcCtD
Delavirdine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000695	0.00272	CcSEcCtD
Delavirdine—Anorexia—Hydroxyurea—head and neck cancer	0.000686	0.00269	CcSEcCtD
Delavirdine—Decreased appetite—Vinblastine—head and neck cancer	0.000686	0.00269	CcSEcCtD
Delavirdine—Cramp muscle—Docetaxel—head and neck cancer	0.000685	0.00268	CcSEcCtD
Delavirdine—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000685	0.00268	CcSEcCtD
Delavirdine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000685	0.00268	CcSEcCtD
Delavirdine—Pain—Vinblastine—head and neck cancer	0.000675	0.00264	CcSEcCtD
Delavirdine—Constipation—Vinblastine—head and neck cancer	0.000675	0.00264	CcSEcCtD
Delavirdine—Dysphagia—Docetaxel—head and neck cancer	0.000658	0.00258	CcSEcCtD
Delavirdine—Feeling abnormal—Vinblastine—head and neck cancer	0.000651	0.00255	CcSEcCtD
Delavirdine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000646	0.00253	CcSEcCtD
Delavirdine—Alopecia—Fluorouracil—head and neck cancer	0.000645	0.00252	CcSEcCtD
Delavirdine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000642	0.00251	CcSEcCtD
Delavirdine—Somnolence—Hydroxyurea—head and neck cancer	0.00064	0.00251	CcSEcCtD
Delavirdine—Erythema—Fluorouracil—head and neck cancer	0.000635	0.00249	CcSEcCtD
Delavirdine—Dyspepsia—Hydroxyurea—head and neck cancer	0.000634	0.00248	CcSEcCtD
Delavirdine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000626	0.00245	CcSEcCtD
Delavirdine—Pancytopenia—Docetaxel—head and neck cancer	0.000625	0.00245	CcSEcCtD
Delavirdine—Abdominal pain—Vinblastine—head and neck cancer	0.000624	0.00244	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000622	0.00243	CcSEcCtD
Delavirdine—Fatigue—Hydroxyurea—head and neck cancer	0.000621	0.00243	CcSEcCtD
Delavirdine—Pain—Hydroxyurea—head and neck cancer	0.000616	0.00241	CcSEcCtD
Delavirdine—Constipation—Hydroxyurea—head and neck cancer	0.000616	0.00241	CcSEcCtD
Delavirdine—Neutropenia—Docetaxel—head and neck cancer	0.000615	0.00241	CcSEcCtD
Delavirdine—Weight increased—Docetaxel—head and neck cancer	0.000599	0.00234	CcSEcCtD
Delavirdine—Vision blurred—Fluorouracil—head and neck cancer	0.000598	0.00234	CcSEcCtD
Delavirdine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000593	0.00232	CcSEcCtD
Delavirdine—Pneumonia—Docetaxel—head and neck cancer	0.00059	0.00231	CcSEcCtD
Delavirdine—Anaemia—Fluorouracil—head and neck cancer	0.000587	0.0023	CcSEcCtD
Delavirdine—Hypersensitivity—Vinblastine—head and neck cancer	0.000582	0.00228	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000581	0.00228	CcSEcCtD
Delavirdine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000575	0.00225	CcSEcCtD
Delavirdine—Stomatitis—Docetaxel—head and neck cancer	0.000572	0.00224	CcSEcCtD
Delavirdine—Jaundice—Docetaxel—head and neck cancer	0.000572	0.00224	CcSEcCtD
Delavirdine—Conjunctivitis—Docetaxel—head and neck cancer	0.00057	0.00223	CcSEcCtD
Delavirdine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000569	0.00223	CcSEcCtD
Delavirdine—Leukopenia—Fluorouracil—head and neck cancer	0.000568	0.00223	CcSEcCtD
Delavirdine—Asthenia—Vinblastine—head and neck cancer	0.000566	0.00222	CcSEcCtD
Delavirdine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000561	0.0185	CbGpPWpGaD
Delavirdine—Epistaxis—Docetaxel—head and neck cancer	0.000553	0.00217	CcSEcCtD
Delavirdine—Chest pain—Fluorouracil—head and neck cancer	0.000541	0.00212	CcSEcCtD
Delavirdine—Myalgia—Fluorouracil—head and neck cancer	0.000541	0.00212	CcSEcCtD
Delavirdine—Diarrhoea—Vinblastine—head and neck cancer	0.00054	0.00211	CcSEcCtD
Delavirdine—Discomfort—Fluorouracil—head and neck cancer	0.000534	0.00209	CcSEcCtD
Delavirdine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00053	0.00208	CcSEcCtD
Delavirdine—Rhinitis—Docetaxel—head and neck cancer	0.000528	0.00207	CcSEcCtD
Delavirdine—Hepatitis—Docetaxel—head and neck cancer	0.000527	0.00206	CcSEcCtD
Delavirdine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000524	0.00205	CcSEcCtD
Delavirdine—Confusional state—Fluorouracil—head and neck cancer	0.000523	0.00205	CcSEcCtD
Delavirdine—Pharyngitis—Docetaxel—head and neck cancer	0.000523	0.00205	CcSEcCtD
Delavirdine—Dizziness—Vinblastine—head and neck cancer	0.000522	0.00204	CcSEcCtD
Delavirdine—Oedema peripheral—Docetaxel—head and neck cancer	0.000519	0.00203	CcSEcCtD
Delavirdine—Oedema—Fluorouracil—head and neck cancer	0.000518	0.00203	CcSEcCtD
Delavirdine—Asthenia—Hydroxyurea—head and neck cancer	0.000517	0.00202	CcSEcCtD
Delavirdine—Infection—Fluorouracil—head and neck cancer	0.000515	0.00202	CcSEcCtD
Delavirdine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000511	0.0169	CbGpPWpGaD
Delavirdine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000508	0.0168	CbGpPWpGaD
Delavirdine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000507	0.00199	CcSEcCtD
Delavirdine—Tachycardia—Fluorouracil—head and neck cancer	0.000506	0.00198	CcSEcCtD
Delavirdine—Vomiting—Vinblastine—head and neck cancer	0.000502	0.00197	CcSEcCtD
Delavirdine—Erythema multiforme—Docetaxel—head and neck cancer	0.000498	0.00195	CcSEcCtD
Delavirdine—Headache—Vinblastine—head and neck cancer	0.000495	0.00194	CcSEcCtD
Delavirdine—Anorexia—Fluorouracil—head and neck cancer	0.000494	0.00193	CcSEcCtD
Delavirdine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000493	0.00193	CcSEcCtD
Delavirdine—Hypotension—Fluorouracil—head and neck cancer	0.000484	0.0019	CcSEcCtD
Delavirdine—Dizziness—Hydroxyurea—head and neck cancer	0.000476	0.00186	CcSEcCtD
Delavirdine—Chills—Docetaxel—head and neck cancer	0.000472	0.00185	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000472	0.00185	CcSEcCtD
Delavirdine—Nausea—Vinblastine—head and neck cancer	0.000469	0.00184	CcSEcCtD
Delavirdine—Insomnia—Fluorouracil—head and neck cancer	0.000469	0.00184	CcSEcCtD
Delavirdine—Paraesthesia—Fluorouracil—head and neck cancer	0.000465	0.00182	CcSEcCtD
Delavirdine—Alopecia—Docetaxel—head and neck cancer	0.000465	0.00182	CcSEcCtD
Delavirdine—Dyspnoea—Fluorouracil—head and neck cancer	0.000462	0.00181	CcSEcCtD
Delavirdine—Somnolence—Fluorouracil—head and neck cancer	0.000461	0.0018	CcSEcCtD
Delavirdine—Malnutrition—Docetaxel—head and neck cancer	0.000458	0.00179	CcSEcCtD
Delavirdine—Erythema—Docetaxel—head and neck cancer	0.000458	0.00179	CcSEcCtD
Delavirdine—Vomiting—Hydroxyurea—head and neck cancer	0.000458	0.00179	CcSEcCtD
Delavirdine—Dyspepsia—Fluorouracil—head and neck cancer	0.000456	0.00179	CcSEcCtD
Delavirdine—Rash—Hydroxyurea—head and neck cancer	0.000454	0.00178	CcSEcCtD
Delavirdine—Dermatitis—Hydroxyurea—head and neck cancer	0.000454	0.00178	CcSEcCtD
Delavirdine—Headache—Hydroxyurea—head and neck cancer	0.000451	0.00177	CcSEcCtD
Delavirdine—Decreased appetite—Fluorouracil—head and neck cancer	0.000451	0.00176	CcSEcCtD
Delavirdine—Dysgeusia—Docetaxel—head and neck cancer	0.000449	0.00176	CcSEcCtD
Delavirdine—CYP3A5—Xenobiotics—CYP1A1—head and neck cancer	0.000448	0.0148	CbGpPWpGaD
Delavirdine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000447	0.00175	CcSEcCtD
Delavirdine—Back pain—Docetaxel—head and neck cancer	0.000443	0.00174	CcSEcCtD
Delavirdine—Pain—Fluorouracil—head and neck cancer	0.000443	0.00174	CcSEcCtD
Delavirdine—Muscle spasms—Docetaxel—head and neck cancer	0.000441	0.00173	CcSEcCtD
Delavirdine—CYP3A5—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00043	0.0142	CbGpPWpGaD
Delavirdine—Nausea—Hydroxyurea—head and neck cancer	0.000428	0.00167	CcSEcCtD
Delavirdine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000427	0.00167	CcSEcCtD
Delavirdine—Anaemia—Docetaxel—head and neck cancer	0.000424	0.00166	CcSEcCtD
Delavirdine—Urticaria—Fluorouracil—head and neck cancer	0.000412	0.00161	CcSEcCtD
Delavirdine—Syncope—Docetaxel—head and neck cancer	0.000411	0.00161	CcSEcCtD
Delavirdine—Leukopenia—Docetaxel—head and neck cancer	0.00041	0.00161	CcSEcCtD
Delavirdine—Body temperature increased—Fluorouracil—head and neck cancer	0.00041	0.0016	CcSEcCtD
Delavirdine—Palpitations—Docetaxel—head and neck cancer	0.000405	0.00159	CcSEcCtD
Delavirdine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000403	0.0133	CbGpPWpGaD
Delavirdine—Loss of consciousness—Docetaxel—head and neck cancer	0.000403	0.00158	CcSEcCtD
Delavirdine—Cough—Docetaxel—head and neck cancer	0.0004	0.00157	CcSEcCtD
Delavirdine—Hypertension—Docetaxel—head and neck cancer	0.000396	0.00155	CcSEcCtD
Delavirdine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000394	0.013	CbGpPWpGaD
Delavirdine—Chest pain—Docetaxel—head and neck cancer	0.00039	0.00153	CcSEcCtD
Delavirdine—Arthralgia—Docetaxel—head and neck cancer	0.00039	0.00153	CcSEcCtD
Delavirdine—Myalgia—Docetaxel—head and neck cancer	0.00039	0.00153	CcSEcCtD
Delavirdine—CYP2C8—Xenobiotics—CYP1A1—head and neck cancer	0.000388	0.0128	CbGpPWpGaD
Delavirdine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000382	0.00149	CcSEcCtD
Delavirdine—Dry mouth—Docetaxel—head and neck cancer	0.000382	0.00149	CcSEcCtD
Delavirdine—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000381	0.0126	CbGpPWpGaD
Delavirdine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00038	0.0126	CbGpPWpGaD
Delavirdine—Confusional state—Docetaxel—head and neck cancer	0.000377	0.00148	CcSEcCtD
Delavirdine—Oedema—Docetaxel—head and neck cancer	0.000374	0.00146	CcSEcCtD
Delavirdine—CYP2C8—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000373	0.0123	CbGpPWpGaD
Delavirdine—Infection—Docetaxel—head and neck cancer	0.000372	0.00145	CcSEcCtD
Delavirdine—Shock—Docetaxel—head and neck cancer	0.000368	0.00144	CcSEcCtD
Delavirdine—Pruritus—Fluorouracil—head and neck cancer	0.000367	0.00144	CcSEcCtD
Delavirdine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000366	0.00143	CcSEcCtD
Delavirdine—Tachycardia—Docetaxel—head and neck cancer	0.000365	0.00143	CcSEcCtD
Delavirdine—Skin disorder—Docetaxel—head and neck cancer	0.000363	0.00142	CcSEcCtD
Delavirdine—Anorexia—Docetaxel—head and neck cancer	0.000357	0.0014	CcSEcCtD
Delavirdine—Diarrhoea—Fluorouracil—head and neck cancer	0.000355	0.00139	CcSEcCtD
Delavirdine—Hypotension—Docetaxel—head and neck cancer	0.00035	0.00137	CcSEcCtD
Delavirdine—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.000346	0.0114	CbGpPWpGaD
Delavirdine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000344	0.0114	CbGpPWpGaD
Delavirdine—Dizziness—Fluorouracil—head and neck cancer	0.000343	0.00134	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000341	0.00133	CcSEcCtD
Delavirdine—Insomnia—Docetaxel—head and neck cancer	0.000338	0.00132	CcSEcCtD
Delavirdine—Paraesthesia—Docetaxel—head and neck cancer	0.000336	0.00131	CcSEcCtD
Delavirdine—Dyspnoea—Docetaxel—head and neck cancer	0.000333	0.00131	CcSEcCtD
Delavirdine—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000333	0.011	CbGpPWpGaD
Delavirdine—Somnolence—Docetaxel—head and neck cancer	0.000333	0.0013	CcSEcCtD
Delavirdine—Vomiting—Fluorouracil—head and neck cancer	0.00033	0.00129	CcSEcCtD
Delavirdine—Dyspepsia—Docetaxel—head and neck cancer	0.000329	0.00129	CcSEcCtD
Delavirdine—Rash—Fluorouracil—head and neck cancer	0.000327	0.00128	CcSEcCtD
Delavirdine—Dermatitis—Fluorouracil—head and neck cancer	0.000326	0.00128	CcSEcCtD
Delavirdine—Decreased appetite—Docetaxel—head and neck cancer	0.000325	0.00127	CcSEcCtD
Delavirdine—Headache—Fluorouracil—head and neck cancer	0.000325	0.00127	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000323	0.00126	CcSEcCtD
Delavirdine—Fatigue—Docetaxel—head and neck cancer	0.000323	0.00126	CcSEcCtD
Delavirdine—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000322	0.0106	CbGpPWpGaD
Delavirdine—Pain—Docetaxel—head and neck cancer	0.00032	0.00125	CcSEcCtD
Delavirdine—Constipation—Docetaxel—head and neck cancer	0.00032	0.00125	CcSEcCtD
Delavirdine—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.000318	0.0105	CbGpPWpGaD
Delavirdine—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000316	0.0104	CbGpPWpGaD
Delavirdine—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000309	0.0102	CbGpPWpGaD
Delavirdine—Feeling abnormal—Docetaxel—head and neck cancer	0.000308	0.00121	CcSEcCtD
Delavirdine—Nausea—Fluorouracil—head and neck cancer	0.000308	0.00121	CcSEcCtD
Delavirdine—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000306	0.0101	CbGpPWpGaD
Delavirdine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000306	0.0012	CcSEcCtD
Delavirdine—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000303	0.01	CbGpPWpGaD
Delavirdine—Abdominal pain—Docetaxel—head and neck cancer	0.000296	0.00116	CcSEcCtD
Delavirdine—Body temperature increased—Docetaxel—head and neck cancer	0.000296	0.00116	CcSEcCtD
Delavirdine—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000293	0.00968	CbGpPWpGaD
Delavirdine—Hypersensitivity—Docetaxel—head and neck cancer	0.000276	0.00108	CcSEcCtD
Delavirdine—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.00027	0.0089	CbGpPWpGaD
Delavirdine—Asthenia—Docetaxel—head and neck cancer	0.000268	0.00105	CcSEcCtD
Delavirdine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000266	0.00878	CbGpPWpGaD
Delavirdine—Pruritus—Docetaxel—head and neck cancer	0.000265	0.00104	CcSEcCtD
Delavirdine—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000259	0.00856	CbGpPWpGaD
Delavirdine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000257	0.00849	CbGpPWpGaD
Delavirdine—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000257	0.00849	CbGpPWpGaD
Delavirdine—Diarrhoea—Docetaxel—head and neck cancer	0.000256	0.001	CcSEcCtD
Delavirdine—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000254	0.00838	CbGpPWpGaD
Delavirdine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000249	0.00821	CbGpPWpGaD
Delavirdine—Dizziness—Docetaxel—head and neck cancer	0.000247	0.000968	CcSEcCtD
Delavirdine—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000239	0.00788	CbGpPWpGaD
Delavirdine—Vomiting—Docetaxel—head and neck cancer	0.000238	0.000931	CcSEcCtD
Delavirdine—CYP3A7—Biological oxidations—NAT2—head and neck cancer	0.000236	0.00781	CbGpPWpGaD
Delavirdine—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000236	0.00781	CbGpPWpGaD
Delavirdine—Rash—Docetaxel—head and neck cancer	0.000236	0.000923	CcSEcCtD
Delavirdine—Dermatitis—Docetaxel—head and neck cancer	0.000236	0.000922	CcSEcCtD
Delavirdine—Headache—Docetaxel—head and neck cancer	0.000234	0.000917	CcSEcCtD
Delavirdine—CYP3A7—Metapathway biotransformation—NAT2—head and neck cancer	0.000233	0.0077	CbGpPWpGaD
Delavirdine—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000226	0.00747	CbGpPWpGaD
Delavirdine—Nausea—Docetaxel—head and neck cancer	0.000222	0.00087	CcSEcCtD
Delavirdine—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000208	0.00688	CbGpPWpGaD
Delavirdine—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000208	0.00687	CbGpPWpGaD
Delavirdine—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.0002	0.00661	CbGpPWpGaD
Delavirdine—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.0002	0.00661	CbGpPWpGaD
Delavirdine—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000188	0.00621	CbGpPWpGaD
Delavirdine—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000186	0.00615	CbGpPWpGaD
Delavirdine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000186	0.00614	CbGpPWpGaD
Delavirdine—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000183	0.00606	CbGpPWpGaD
Delavirdine—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000177	0.00583	CbGpPWpGaD
Delavirdine—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000176	0.00581	CbGpPWpGaD
Delavirdine—CYP3A5—Biological oxidations—NAT2—head and neck cancer	0.000171	0.00564	CbGpPWpGaD
Delavirdine—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	0.000169	0.00557	CbGpPWpGaD
Delavirdine—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000168	0.00554	CbGpPWpGaD
Delavirdine—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000166	0.00549	CbGpPWpGaD
Delavirdine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000161	0.00531	CbGpPWpGaD
Delavirdine—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000159	0.00524	CbGpPWpGaD
Delavirdine—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000153	0.00506	CbGpPWpGaD
Delavirdine—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000152	0.005	CbGpPWpGaD
Delavirdine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000151	0.00497	CbGpPWpGaD
Delavirdine—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000148	0.00489	CbGpPWpGaD
Delavirdine—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000146	0.00482	CbGpPWpGaD
Delavirdine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000144	0.00474	CbGpPWpGaD
Delavirdine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000142	0.00468	CbGpPWpGaD
Delavirdine—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000138	0.00457	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000138	0.00457	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000138	0.00457	CbGpPWpGaD
Delavirdine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000132	0.00436	CbGpPWpGaD
Delavirdine—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000132	0.00436	CbGpPWpGaD
Delavirdine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000131	0.00433	CbGpPWpGaD
Delavirdine—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000131	0.00432	CbGpPWpGaD
Delavirdine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00013	0.00431	CbGpPWpGaD
Delavirdine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00013	0.00431	CbGpPWpGaD
Delavirdine—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.00013	0.0043	CbGpPWpGaD
Delavirdine—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00013	0.00428	CbGpPWpGaD
Delavirdine—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000129	0.00427	CbGpPWpGaD
Delavirdine—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000122	0.00401	CbGpPWpGaD
Delavirdine—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.00012	0.00398	CbGpPWpGaD
Delavirdine—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.00012	0.00396	CbGpPWpGaD
Delavirdine—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000119	0.00392	CbGpPWpGaD
Delavirdine—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	0.000117	0.00386	CbGpPWpGaD
Delavirdine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000116	0.00385	CbGpPWpGaD
Delavirdine—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	0.000115	0.0038	CbGpPWpGaD
Delavirdine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000112	0.0037	CbGpPWpGaD
Delavirdine—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000111	0.00366	CbGpPWpGaD
Delavirdine—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	0.000111	0.00366	CbGpPWpGaD
Delavirdine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00011	0.00365	CbGpPWpGaD
Delavirdine—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000109	0.00361	CbGpPWpGaD
Delavirdine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000107	0.00354	CbGpPWpGaD
Delavirdine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000107	0.00353	CbGpPWpGaD
Delavirdine—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000106	0.00351	CbGpPWpGaD
Delavirdine—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000103	0.0034	CbGpPWpGaD
Delavirdine—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000102	0.00335	CbGpPWpGaD
Delavirdine—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	9.89e-05	0.00326	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—UROD—head and neck cancer	9.74e-05	0.00322	CbGpPWpGaD
Delavirdine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.08e-05	0.003	CbGpPWpGaD
Delavirdine—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	9.01e-05	0.00298	CbGpPWpGaD
Delavirdine—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	8.69e-05	0.00287	CbGpPWpGaD
Delavirdine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	8.64e-05	0.00285	CbGpPWpGaD
Delavirdine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	8.53e-05	0.00282	CbGpPWpGaD
Delavirdine—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	8.44e-05	0.00279	CbGpPWpGaD
Delavirdine—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	8.33e-05	0.00275	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	8.23e-05	0.00272	CbGpPWpGaD
Delavirdine—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	8e-05	0.00264	CbGpPWpGaD
Delavirdine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	7.95e-05	0.00262	CbGpPWpGaD
Delavirdine—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	7.89e-05	0.00261	CbGpPWpGaD
Delavirdine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	7.84e-05	0.00259	CbGpPWpGaD
Delavirdine—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	7.7e-05	0.00254	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	7.63e-05	0.00252	CbGpPWpGaD
Delavirdine—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	7.31e-05	0.00241	CbGpPWpGaD
Delavirdine—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	7.21e-05	0.00238	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—UROD—head and neck cancer	7.04e-05	0.00232	CbGpPWpGaD
Delavirdine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7e-05	0.00231	CbGpPWpGaD
Delavirdine—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	6.93e-05	0.00229	CbGpPWpGaD
Delavirdine—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	6.84e-05	0.00226	CbGpPWpGaD
Delavirdine—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	6.53e-05	0.00215	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	6.49e-05	0.00214	CbGpPWpGaD
Delavirdine—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	6.44e-05	0.00213	CbGpPWpGaD
Delavirdine—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	6.19e-05	0.00204	CbGpPWpGaD
Delavirdine—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	6.1e-05	0.00201	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—UROD—head and neck cancer	6.1e-05	0.00201	CbGpPWpGaD
Delavirdine—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	6e-05	0.00198	CbGpPWpGaD
Delavirdine—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	5.95e-05	0.00196	CbGpPWpGaD
Delavirdine—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	5.92e-05	0.00195	CbGpPWpGaD
Delavirdine—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	5.87e-05	0.00194	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	5.84e-05	0.00193	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	5.84e-05	0.00193	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	5.84e-05	0.00193	CbGpPWpGaD
Delavirdine—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	5.69e-05	0.00188	CbGpPWpGaD
Delavirdine—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	5.64e-05	0.00186	CbGpPWpGaD
Delavirdine—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	5.61e-05	0.00185	CbGpPWpGaD
Delavirdine—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	5.56e-05	0.00184	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—UROD—head and neck cancer	5.44e-05	0.0018	CbGpPWpGaD
Delavirdine—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	5.09e-05	0.00168	CbGpPWpGaD
Delavirdine—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	5.02e-05	0.00166	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—UROD—head and neck cancer	5.01e-05	0.00165	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—UROD—head and neck cancer	4.96e-05	0.00164	CbGpPWpGaD
Delavirdine—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	4.82e-05	0.00159	CbGpPWpGaD
Delavirdine—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	4.75e-05	0.00157	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.73e-05	0.00156	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	4.69e-05	0.00155	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—UROD—head and neck cancer	4.24e-05	0.0014	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.22e-05	0.00139	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—NAT2—head and neck cancer	4.04e-05	0.00134	CbGpPWpGaD
Delavirdine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	3.92e-05	0.0013	CbGpPWpGaD
Delavirdine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	3.87e-05	0.00128	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.85e-05	0.00127	CbGpPWpGaD
Delavirdine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	3.72e-05	0.00123	CbGpPWpGaD
Delavirdine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	3.67e-05	0.00121	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—DPYD—head and neck cancer	3.55e-05	0.00117	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—YAP1—head and neck cancer	3.36e-05	0.00111	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.29e-05	0.00109	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—UROD—head and neck cancer	3.27e-05	0.00108	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—NAT2—head and neck cancer	2.92e-05	0.000965	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.69e-05	0.000888	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.66e-05	0.000879	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—DPYD—head and neck cancer	2.56e-05	0.000846	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—NAT2—head and neck cancer	2.53e-05	0.000836	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—YAP1—head and neck cancer	2.43e-05	0.000803	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.4e-05	0.000792	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.38e-05	0.000784	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—NAT2—head and neck cancer	2.26e-05	0.000746	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—DPYD—head and neck cancer	2.22e-05	0.000733	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.19e-05	0.000723	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.17e-05	0.000715	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—YAP1—head and neck cancer	2.11e-05	0.000696	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—NAT2—head and neck cancer	2.08e-05	0.000686	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—NAT2—head and neck cancer	2.06e-05	0.00068	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—TYMS—head and neck cancer	2.02e-05	0.000667	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—GSTM1—head and neck cancer	2e-05	0.000659	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—DPYD—head and neck cancer	1.98e-05	0.000654	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—GPX1—head and neck cancer	1.91e-05	0.000631	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—CYP1A1—head and neck cancer	1.89e-05	0.000625	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—YAP1—head and neck cancer	1.88e-05	0.000621	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.87e-05	0.000617	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.85e-05	0.000611	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—DPYD—head and neck cancer	1.82e-05	0.000602	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—DPYD—head and neck cancer	1.81e-05	0.000597	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—NAT2—head and neck cancer	1.76e-05	0.000581	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—YAP1—head and neck cancer	1.73e-05	0.000571	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—YAP1—head and neck cancer	1.71e-05	0.000566	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.58e-05	0.000523	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—DPYD—head and neck cancer	1.54e-05	0.00051	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—YAP1—head and neck cancer	1.47e-05	0.000484	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—TYMS—head and neck cancer	1.46e-05	0.000482	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GSTM1—head and neck cancer	1.44e-05	0.000477	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.41e-05	0.000467	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—GPX1—head and neck cancer	1.38e-05	0.000456	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.38e-05	0.000456	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CYP1A1—head and neck cancer	1.37e-05	0.000452	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—NAT2—head and neck cancer	1.36e-05	0.000449	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.29e-05	0.000425	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—TYMS—head and neck cancer	1.27e-05	0.000418	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.25e-05	0.000413	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.23e-05	0.000407	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—GPX1—head and neck cancer	1.2e-05	0.000395	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—DPYD—head and neck cancer	1.19e-05	0.000393	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.19e-05	0.000391	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—YAP1—head and neck cancer	1.13e-05	0.000373	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—TYMS—head and neck cancer	1.13e-05	0.000373	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PTGS2—head and neck cancer	1.13e-05	0.000372	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.12e-05	0.000371	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.12e-05	0.000369	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.1e-05	0.000363	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—GPX1—head and neck cancer	1.07e-05	0.000353	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.06e-05	0.000349	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—TYMS—head and neck cancer	1.04e-05	0.000343	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—TYMS—head and neck cancer	1.03e-05	0.00034	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.03e-05	0.000339	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.02e-05	0.000336	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—GPX1—head and neck cancer	9.83e-06	0.000325	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PTEN—head and neck cancer	9.82e-06	0.000324	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—GPX1—head and neck cancer	9.75e-06	0.000322	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.74e-06	0.000322	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	9.73e-06	0.000321	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	9.65e-06	0.000319	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.6e-06	0.000317	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—TYMS—head and neck cancer	8.8e-06	0.00029	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GSTM1—head and neck cancer	8.7e-06	0.000287	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.69e-06	0.000287	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—GPX1—head and neck cancer	8.33e-06	0.000275	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	8.24e-06	0.000272	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PTGS2—head and neck cancer	8.14e-06	0.000269	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.93e-06	0.000262	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PTEN—head and neck cancer	7.1e-06	0.000234	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PTGS2—head and neck cancer	7.05e-06	0.000233	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PIK3CA—head and neck cancer	6.93e-06	0.000229	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—TYMS—head and neck cancer	6.79e-06	0.000224	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.77e-06	0.000224	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GSTM1—head and neck cancer	6.71e-06	0.000222	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—GPX1—head and neck cancer	6.43e-06	0.000212	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	6.36e-06	0.00021	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PTGS2—head and neck cancer	6.29e-06	0.000208	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PTEN—head and neck cancer	6.15e-06	0.000203	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PTGS2—head and neck cancer	5.79e-06	0.000191	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PTGS2—head and neck cancer	5.74e-06	0.000189	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—AKT1—head and neck cancer	5.66e-06	0.000187	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PTEN—head and neck cancer	5.49e-06	0.000181	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PTEN—head and neck cancer	5.05e-06	0.000167	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PIK3CA—head and neck cancer	5.01e-06	0.000165	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PTEN—head and neck cancer	5e-06	0.000165	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PTGS2—head and neck cancer	4.9e-06	0.000162	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PIK3CA—head and neck cancer	4.34e-06	0.000143	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PTEN—head and neck cancer	4.28e-06	0.000141	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—AKT1—head and neck cancer	4.09e-06	0.000135	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	3.87e-06	0.000128	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PTGS2—head and neck cancer	3.78e-06	0.000125	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	3.56e-06	0.000118	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—AKT1—head and neck cancer	3.54e-06	0.000117	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	3.53e-06	0.000117	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PTEN—head and neck cancer	3.3e-06	0.000109	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—AKT1—head and neck cancer	3.16e-06	0.000104	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	3.02e-06	9.96e-05	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—AKT1—head and neck cancer	2.91e-06	9.6e-05	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—AKT1—head and neck cancer	2.88e-06	9.52e-05	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—AKT1—head and neck cancer	2.46e-06	8.14e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.33e-06	7.69e-05	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—AKT1—head and neck cancer	1.9e-06	6.28e-05	CbGpPWpGaD
